Synthesis, characterization, and application of novel biodegradable self-assembled 2-(N-phthalimido) ethyl-palmitate nanoparticles for cancer therapy

Journal of Nanoparticle Research

Volumn 12, Issue 3, 2010, Pages 801-810

  Kasoju, Naresh ^a   Bora, Debajeet K ^a   Bhonde, Ramesh R ^b   Bora, Utpal ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Anticancer; Conjugate; Nanomedicine; Nanoparticle; Phthalimide; Self assembly

Indexed keywords

ANTICANCER; ANTICANCER ACTIVITIES; ANTICANCER EFFECTS; ATOMIC FORCE MICROSCOPES; BIODEGRADABLE NANOPARTICLE; CANCER CELLS; CANCER CHEMOTHERAPY; CANCER THERAPY; CHARACTERIZATION STUDIES; DRUG LOADING; DYNAMIC LIGHT SCATTERING TECHNIQUE; ETHYL PALMITATE; FOURIER TRANSFORM INFRARED; HELA CELL; NANOMEDICINE; NANOMEDICINES; PHTHALIMIDE; PHTHALIMIDE MOIETIES; SELF ASSEMBLY PROCESS; SELF-ASSEMBLED; TRANSMISSION ELECTRON MICROSCOPE;

CHEMOTHERAPY; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORMS; LIGHT TRANSMISSION; LIQUID CHROMATOGRAPHY; MEDICAL NANOTECHNOLOGY; MICROSCOPES; NANOPARTICLES; RESONANCE; SELF ASSEMBLY; TRANSMISSION ELECTRON MICROSCOPY; WAVELET TRANSFORMS; X RAY DIFFRACTION;

CELL CULTURE;

2 (N PHTHALIMIDO) ETHYL PALMITATE; NANOPARTICLE; PHTHALIMIDE; SELF ASSEMBLED MONOLAYER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BIODEGRADABILITY; CANCER CELL; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL CULTURE; CELL KILLING; CELL LINE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CONJUGATION; DRUG POTENCY; DRUG SYNTHESIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 77955091000     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-009-9754-3     Document Type: Article

References (25)

1. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649-1659
2. Chan SH, Lam KH, Chiu CH et al (2009) The preparation and in vitro antiproliferative activity of phthalimide based ketones on MDAMB-231 and SKHep-1 human carcinoma cell lines. Eur J Med Chem 44:2736-2740
3. Corti M, Cantu L, Brocca P et al (2007) Self-assembly in glycolipids. Curr Opin Colloid Interface Sci 12:148-154
4. Das RK, Kasoju N, Bora U (2009) Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. doi:10.1016/ j.nano.2009.05.009
5. Feng SS, Chien (2003) Chemotherapeutic engineering: application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Eng Sci 58:14-4087
6. Feng SS, Mu L, Win KY et al (2004) Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 11:413-424
7. Gradishar WJ (2006) Albumin-bound paclitaxel: a next-generation taxane. Expert Opin Pharmacother 7:1041-1053
8. Gu FX, Karnik R, Wang AZ et al (2007) Targeted nanoparticles for cancer therapy. Nanotoday 2:14-21
9. Hall IH, Wong OT, Scovill JP (1995) The cytotoxicity of N-pyridinyl and N-quinolinyl substituted derivatives of phthalimide and succinimide. Biomed Pharmacother 5:251-258
10. Hou D, Xie C, Huang K et al (2003) The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 24:1781-1785
11. Janes KA, Fresneau MP, Marazuela A et al (2001) Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 73:255-267
12. Li L, Braiteh FS, Kurzrock R (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104:1322-1331
13. Lima LM, Castro P, Machado AL et al (2002a) Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. Bioorg Med Chem 10:3067-3073
14. Lima ML, de Brito FCF, de Souza SD et al (2002b) Novel phthalimide derivatives, designed as leukotriene D4 receptor antagonists. Bioorg Med Chem Lett 12:1533-1535
15. Maeda H, Wu J, Sawa T et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271-284
16. Miele E, Spinelli GP, Miele E et al (2009) Albumin-bound formulation of paclitaxel (Abraxane (R) ABI-007) in the treatment of breast cancer. Int J Nanomed 4:99-105
17. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
18. Nasongkla N, Shuai X, Ai H et al (2004) cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl 43:6323-6327
19. Noguchi T, Fujimoto H, Sano H et al (2005) Angiogenesis inhibitors derived from thalidomide. Bioorg Med Chem Lett 15:5509-5513
20. Noguchi-Yachide T, Aoyama A, Makishima M et al (2007) Liver X receptor antagonists with a phthalimide skeleton derived from thalidomide-related glucosidase inhibitors. Bioorg Med Chem Lett 17:3957-3961 (Pubitemid 46920933)
21. Sahu A, Bora U, Kasoju N et al (2008a) Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)-palmitate nanocarrier for curcumin delivery to cancer cells. Acta Biomater 4:1752-1761
22. Sahu A, Kasoju N, Bora U (2008b) Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells. Biomacromolecules 9:2905-2912
23. Shinji C, Nakamura T, Maeda S et al (2005) Design and synthesis of phthalimide-type histone deacetylase inhibitors. Bioorg Med Chem Lett 15:4427-4431
24. Wang SN, Deng YH, Xu H et al (2006) Synthesis of a novel galactosylated lipid and its application to the hepatocyteselective targeting of liposomal doxorubicin. Eur J Pharm Biopharm 62:32-38
25. Zhang L, Chan JM, Gu FX et al (2008) Self-assembled lipidpolymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano 2:1696-1702